DataString Consulting Company Logo
DataString Consulting Company Logo
Aortic Valve Replacement Devices Market
Home»Recent Reports»Aortic Valve Replacement Devices Market

Aortic Valve Replacement Devices Market

Author: Debadatta Patel - Senior Consultant, Report ID - DS1801104, Published - January 2025

Segmented in Type (Biological/Tissue Aortic, Mechanical Aortic), Surgical Approach (Open-heart Surgery, Minimally Invasive Surgery), Patient Age Group, Implantation Procedure and Regions - Global Industry Analysis, Size, Share, Trends, and Forecast 2024 – 2034

Share this report:

Global Aortic Valve Replacement Devices
Market Outlook

The worldwide industry for Aortic Valve Replacement Devices is experiencing a transformation that highlights its capacity to revolutionize surgical treatments effectively. The market, for Aortic valve replacement devices was estimated at $8.5 billion in 2024. It is anticipated to increase to $12.3 billion by 2030 with projections indicating a growth to around $16.6 billion by 2035. This expansion represents a compound annual growth rate (CAGR) of 6.2% over the forecast period. Incorporating bioengineering and medical advancements have resulted in the creation of these devices that are reshaping heart valve procedures by offering treatment alternatives to an expanding base and showcasing remarkable enhancements, in patient outcomes and quality of life.


Heart valve replacement devices for the aorta are innovations tailored to replace a defective aortic valve in the human heart with features such as compatibility with the bodys biology and long lasting performance, in natural conditions.


Market Size Forecast & Key Insights

2019
$8.5B2024
2029
$15.6B2034

Absolute Growth Opportunity = $7.0B

The Aortic Valve Replacement Devices market is projected to grow from $8.5 billion in 2024 to $15.6 billion in 2034. This represents a CAGR of 6.2%, reflecting rising demand across Therapeutic Correction of Aortic Valve Disease, Mitigating Rheumatic Heart Disease Impact and Geriatric Care.

The Aortic Valve Replacement Devices market is set to add $7.0 billion between 2024 and 2034, with manufacturer targeting Minimally Invasive Surgery & undefined Surgical Approach projected to gain a larger market share.

With Rising prevalence of heart disorders, and Advancements in technology, Aortic Valve Replacement Devices market to expand 82% between 2024 and 2034.

Opportunities in the Aortic Valve Replacement Devices Market

Advancements in Bioprosthetic Devices

The growing number of individuals along with a higher likelihood of heart conditions like coronary artery disease is leading to a higher need for aortic valve replacement devices in the market today. A new trend is emerging with devices that are crafted from tissue rather than mechanical parts which eliminates the necessity for blood thinning medications after implantation and is becoming a more favored choice, among patients. Companies that create and produce effective bioprosthetic aortic valves have the potential to capture a substantial share of this expanding market segment.

Growth Opportunities in North America and Europe

Europe Outlook

In the Aortic Valve Replacement Devices market in Europe closely mirrors North America's trends due to a growing population and a rise in heart disease cases; however faces tough competition from North America due to less advanced healthcare systems and lower healthcare spending levels Nevertheless there are rising calls for minimally invasive procedures and strong plans for device advancements that offer hopeful avenues, for growth.

North America Outlook

North America stands out as the region in the Aortic Valve Replacement Devices market due to its well develop healthcare system and significant investment in healthcare along with a high incidence of heart diseases present there. The presence of companies and continuous research and development efforts alongside the quick adoption of advanced medical devices further solidify its leading position in this market segment. The competition is intense in this region with opportunities arising from the untapped potential, among individuals afflicted by Aortic Stenosis and other heart valve conditions.

North America Outlook

North America stands out as the region in the Aortic Valve Replacement Devices market due to its well develop healthcare system and significant investment in healthcare along with a high incidence of heart diseases present there. The presence of companies and continuous research and development efforts alongside the quick adoption of advanced medical devices further solidify its leading position in this market segment. The competition is intense in this region with opportunities arising from the untapped potential, among individuals afflicted by Aortic Stenosis and other heart valve conditions.

Europe Outlook

In the Aortic Valve Replacement Devices market in Europe closely mirrors North America's trends due to a growing population and a rise in heart disease cases; however faces tough competition from North America due to less advanced healthcare systems and lower healthcare spending levels Nevertheless there are rising calls for minimally invasive procedures and strong plans for device advancements that offer hopeful avenues, for growth.

Growth Opportunities in North America and Europe

Established and Emerging Market's Growth Trend 2025–2034

1

Major Markets : United States, Germany, Japan, China, France are expected to grow at 4.0% to 6.0% CAGR

2

Emerging Markets : Brazil, India, South Africa are expected to grow at 7.1% to 8.6% CAGR

Market Analysis Chart

The market for valve replacement devices has experienced significant growth due to various factors at play. The primary drivers include the growing number of individuals globally the higher incidence of heart conditions and advancements in technology. As the population ages it leads to a larger group of patients at risk of heart diseases. This highlights the increasing demand, for advanced aortic valve replacement devices.

Recent Developments and Technological Advancement

December 2024

Edwards Lifesciences introduced a minimally invasive aortic valve replacement tool that emphasizes enhanced device longevity and increased patient comfort.

October 2024

Medtronic has revealed that they are incorporating AI into their current aortic valve replacement equipment to improve surgical accuracy.

July 2024

Boston Scientific unveiled a biological aortic valve replacement that has received FDA approval for its innovative approach, to minimizing complications after surgery.

Lately the developments in Aortic Valve Replacement Devices have had an impact on the potential expansion of the market sector. The primary companies, in this field are focused on investing in technologies and conducting research to keep up with rising needs and enhance patient results.

Impact of Industry Transitions on the Aortic Valve Replacement Devices Market

As a core segment of the Medical Device industry, the Aortic Valve Replacement Devices market develops in line with broader industry shifts. Over recent years, transitions such as Shift to Minimally Invasive Procedures and Rising Demand for Transcatheter Aortic Valve Replacement have redefined priorities across the Medical Device sector, influencing how the Aortic Valve Replacement Devices market evolves in terms of demand, applications and competitive dynamics. These transitions highlight the structural changes shaping long-term growth opportunities.

1

Shift to Minimally Invasive Procedures:

The market for Aortic Valve Replacement Devices is shifting towards invasive surgeries which are safer and result in quicker recovery times compared to traditional open heart procedures due to technological advancements making the procedures more efficient and effective, for patients well being and comfort levels.

2

Rising Demand for Transcatheter Aortic Valve Replacement :

there has been an increase, in the embrace and utilization of Transcatheter Aortic Valve Replacement .

Global Events Shaping Future Growth

The chart below highlights how external events including emerging market developments, regulatory changes, and technological disruptions, have added another layer of complexity to the Medical Device industry. These events have disrupted supply networks, changed consumption behavior, and reshaped growth patterns. Together with structural industry transitions, they demonstrate how changes within the Medical Device industry cascade into the Aortic Valve Replacement Devices market, setting the stage for its future growth trajectory.

Market Dynamics and Supply Chain

Driver: Rising Prevalence of Heart Disorders, and Aging Global Populations

One key factor that influences this market is also the increasing occurrence of heart conditions like stenosis and mitral regurgitation since these issues frequently require valve replacement surgeries; the need, for such devices is also closely tied to the frequency of these health concerns.
The population of the world is also getting older steadily in developed nations and elderly individuals are also at a higher risk for heart issues that necessitate aortic valve replacement surgery; as a result of this demographic shift leading to an increased need, for such medical devices.
The ongoing enhancements and progress in aortic valve replacement technology serve as a major catalyst for the market growth in this area. These improvements are also enhancing the procedures effectiveness. Reducing invasiveness levels. Factors that are also increasingly attractive, to both medical professionals and patients alike.

Restraint: High Cost of Devices

The high cost of Aortic Valve Replacement Devices is an obstacle to market expansion as it renders them unaffordable for a considerable number of patients in developing nations with substantial, out of pocket expenses. The expensive price serves as an obstacle that hinders the markets expansion.

Challenge: Regulatory Hurdles

One significant obstacle to the expansion of the market, for Aortic Valve Replacement Devices is the difficulty posed by regulatory procedures.

Supply Chain Landscape

Raw Material Acquisition

Zimmer Biomet

Bristol-Myers Squibb

Design & Production

Medtronic

Abbott Laboratories

Edwards Lifesciences

Distribution & Marketing
Boston Scientific Corporation / Johnson and Johnson
End Users
Hospitals / Specialty Clinics
Raw Material Acquisition

Zimmer Biomet

Bristol-Myers Squibb

Design & Production

Medtronic

Abbott Laboratories

Edwards Lifesciences

Distribution & Marketing

Boston Scientific Corporation

Johnson and Johnson

End Users

Hospitals

Specialty Clinics

Banner LogoBanner Logo

Leading Providers and Their Strategies

Application AreaIndustryLeadingProvidersProvider Strategies
Transcatheter Aortic Valve Replacement (TAVR)
Medical Devices
Edwards Lifesciences, Medtronic
Focus on minimally invasive procedures and utilization of advanced material for device manufacture
Surgical Aortic Valve Replacement (SAVR)
Healthcare
Boston Scientific, Abbott Laboratories
Continuous innovation, adherence to regulatory standards and focus on client satisfaction
Research and Development Initiatives
Bio Medical Research
Symetis, St. Jude Medical
Investment in research, emphasis on clinical trials, and collaboration with academic institutions

Elevate your strategic vision with in-depth analysis of key applications, leading market players, and their strategies. The report analyzes industry leaders' views and statements on the Aortic Valve Replacement Devices market's present and future growth.

Our research is created following strict editorial standards. See our Editorial Policy

Applications of Aortic Valve Replacement Devices in Mitigating Rheumatic Heart Disease Impact, Geriatric Care and Therapeutic Correction of Aortic Valve Disease

Mitigating Rheumatic Heart Disease Impact

Untreated streptococcal throat infections or rheumatic fever can lead to a prevalence of rheumatic heart disease in developing regions. This underscores the importance of valve replacement devices, as essential healthcare resources.

Geriatric Care

The aging population around the world is leading to a growing need for Aortic Valve Replacement Devices since older individuals are at a risk of conditions such as calcific aortic stenosis that require valve replacement procedures to be performed. Our two key players, in this field are Boston Scientific and Abbott Laboratories who have developed technologies aimed at lowering hospital stays and improving recovery times for patients.

Therapeutic Correction of Aortic Valve Disease

The main purpose of Aortic Valve Replacement Devices is to help in fixing or substituting an aortic valve in individuals suffering from aortic valve disease. These devices offer benefits such as better heart function and alleviation of symptoms leading to an overall improvement in the quality of life. Companies like Edwards Lifesciences and Medtronic lead the way, in this field by providing advanced and trustworthy replacement choices that are minimally invasive.

Aortic Valve Replacement Devices vs. Substitutes:
Performance and Positioning Analysis

The Aortic Valve Replacement Devices provide an intrusive cardiovascular solution, than conventional surgery does With the progression of technology and growing patient interest these devices are set to experience considerable market expansion

Aortic Valve Replacement Devices
  • Transcatheter Aortic Valve Implantation /
  • Balloon Valvuloplasty /
  • Drug Therapy
    Increased life expectancy, improved quality of life
    Risk of prosthetic valve endocarditis, occurrence of paravalvular leaks
    Noninvasive nature, Reduced recovery times
    Risk of leakage, Less effective for severe conditions

Aortic Valve Replacement Devices vs. Substitutes:
Performance and Positioning Analysis

Aortic Valve Replacement Devices

  • Increased life expectancy, improved quality of life
  • Risk of prosthetic valve endocarditis, occurrence of paravalvular leaks

Transcatheter Aortic Valve Implantation / Balloon Valvuloplasty / Drug Therapy

  • Noninvasive nature, Reduced recovery times
  • Risk of leakage, Less effective for severe conditions

The Aortic Valve Replacement Devices provide an intrusive cardiovascular solution, than conventional surgery does With the progression of technology and growing patient interest these devices are set to experience considerable market expansion

Loading...

Research Methodology

This market research methodology defines the Aortic Valve Replacement Devices market scope, gathers reliable data, and validates findings using integrated primary and secondary research. Our systematic framework ensures precise market sizing, growth trend analysis, and competitive benchmarking.


Secondary Research Approach


We begin secondary research by defining the targeted market at Country and Regional levels. As part of the Medical Device ecosystem, we analyze Aortic Valve Replacement Devices across Biological/Tissue Aortic and Mechanical Aortic Applications. Our team gathers data systematically from country level ministerial sources, industry associations & federations, trade databases, company annual & quarterly reports and other credential sources, enabling us to map global and regional market size, pricing trends, regulatory standards, and technology advancements.


Key Sources Referenced:


We benchmark competitors such as Edwards Lifesciences Corporation, Medtronic Plc, and Boston Scientific Corporation by reviewing company financial statements, and regulatory filings. Our secondary insights identify key market drivers and constraints, forming the analytical foundation for primary research.


Primary Research Methods


We conduct structured interviews and surveys with industry stakeholders, including Raw Material Acquisition, Design & Production, and Distribution & Marketing. Our geographic coverage spans Americas (40%), Europe (30%), Asia-Pacific (25%) and Middle East & Africa (5%). Our online surveys generally achieve a response rate of above 65%, and telephone interviews yield 60%, resulting in above 92% confidence level with a ±7% margin of error.


Through targeted questionnaires and in-depth interviews, we capture purchase intent, adoption barriers, brand perception across Segment Type. We use interview guides to ensure consistency and anonymous survey options to mitigate response bias. These primary insights validate secondary findings and align market sizing with real-world conditions.


Market Engineering & Data Analysis Framework


Our data analysis framework integrates Top-Down, Bottom-Up, and Company Market Share approaches to estimate and project market size with precision.


Top-down & Bottom-Up Process


In Top-down approach, we disaggregate global Medical Device revenues to estimate the Aortic Valve Replacement Devices segment, using historical growth patterns to set baseline trends. Simultaneously, in Bottom-up approach, we aggregate Country-Level Demand Data to derive regional and global forecasts, which provide granular consumption insights. By reconciling both approaches, we ensure statistical precision and cross-validation accuracy.


We evaluate the supply chain, spanning Raw Material Acquisition (Zimmer Biomet, Bristol-Myers Squibb), Design & Production (Medtronic, Abbott Laboratories), and Distribution & Marketing. Our parallel substitute analysis examines Transcatheter Aortic Valve Implantation, Balloon Valvuloplasty, and Drug Therapy, highlighting diversification opportunities and competitive risks.


Company Market Share & Benchmarking


We benchmark leading companies such as Edwards Lifesciences Corporation, Medtronic Plc, and Boston Scientific Corporation, analyzing their capabilities in pricing, product features, technology adoption, and distribution reach. By assessing company-level revenues and product portfolios, we derive market share comparisons, clarifying competitive positioning and growth trajectories across the ecosystem.


Our integration of data triangulation, supply chain evaluation, and company benchmarking, supported by our proprietary Directional Superposition methodology enables us to deliver precise forecasts and actionable strategic insights into the Aortic Valve Replacement Devices market.


Quality Assurance and Compliance


We cross-reference secondary data with primary inputs and external expert reviews to confirm consistency. Further, we use stratified sampling, anonymous surveys, third-party interviews, and time-based sampling to reduce bias and strengthen our results.


Our methodology is developed in alignment with ISO 20252 standards and ICC/ESOMAR guidelines for research ethics. The study methodology follows globally recognized frameworks such as ISO 20252 and ICC codes of practice.

rm

Aortic Valve Replacement Devices Market Data: Size, Segmentation & Growth Forecast

Report AttributeDetails
Market Value in 2025USD 9.1 billion
Revenue Forecast in 2034USD 15.6 billion
Growth RateCAGR of 6.2% from 2025 to 2034
Base Year for Estimation2024
Industry Revenue 20248.5 billion
Growth OpportunityUSD 7.0 billion
Historical Data2019 - 2023
Growth Projection / Forecast Period2025 - 2034
Market Size UnitsMarket Revenue in USD billion and Industry Statistics
Market Size 20248.5 billion USD
Market Size 202710.2 billion USD
Market Size 202911.5 billion USD
Market Size 203012.3 billion USD
Market Size 203415.6 billion USD
Market Size 203516.6 billion USD
Report CoverageMarket revenue for past 5 years and forecast for future 10 years, Competitive Analysis & Company Market Share, Strategic Insights & trends
Segments CoveredType, Surgical Approach, Patient Age Group, Implantation Procedure
Regional scopeNorth America, Europe, Asia Pacific, Latin America and Middle East & Africa
Country scopeU.S., Canada, Mexico, UK, Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Mexico, Argentina, Saudi Arabia, UAE and South Africa
Companies ProfiledEdwards Lifesciences Corporation, Medtronic Plc, Boston Scientific Corporation, Jude Medical Inc, CryoLife Inc, Symetis SA, Direct Flow medical Inc, Jenavalve Technology Inc, LivaNova Plc, TTK HealthCare, Colibri Heart Valve LLC and Braile Biomdica
CustomizationFree customization at segment, region or country scope and direct contact with report analyst team for 10 to 20 working hours for any additional niche requirement which is almost equivalent to 10% of report value

Explore Report Features and Data Packages

Industry Insight Report

$ 4200
Unlock Multi-User Access for just $999 more
i
No Payment Before Report Delivery
Flexible Payment Options
Additional Features
Customization Available
i
Excel Data Pack Included
Free Analyst Support
i
Industry Expert-Validated Insights
100% Confidentiality Guaranteed
Fast Delivery (24–72 hours)
i
Get Report Now

Strategic Growth Advisory

Unrivaled Custom Market Intelligence & Strategic Advisory for Business Growth and Competitive Excellence

  • Assess and prioritize high-value markets with precision
  • Craft tailored entry and expansion roadmaps
  • De-risk investments through rigorous market intelligence
  • Architect dynamic pricing frameworks aligned to value creation
  • Unlock sustainable margin enhancement opportunities
  • Benchmark performance against global industry leaders
  • Strategically realign portfolios to future growth drivers
  • Accelerate commercialization of breakthrough offerings
  • Harness market foresight and technology shifts to fuel innovation

Discover our Strategic Growth Advisory Services »

Table of Contents

Industry Insights Report - Table Of Contents

Chapter 1

Executive Summary

Major Markets & Their Performance - Statistical Snapshots

Chapter 2

Research Methodology

2.1Axioms & Postulates
2.2Market Introduction & Research MethodologyEstimation & Forecast Parameters / Major Databases & Sources
Chapter 3

Market Dynamics

3.1Market OverviewDrivers / Restraints / Opportunities / M4 Factors
3.2Market Trends
3.2.1Introduction & Narratives
3.2.2Market Trends - Impact Analysis(Short, Medium & Long Term Impacts)
3.3Supply Chain Analysis
3.4Porter's Five ForcesSuppliers & Buyers' Bargaining Power, Threat of Substitution & New Market Entrants, Competitive Rivalry
Chapter 4

Aortic Valve Replacement Devices Market Size, Opportunities & Strategic Insights, by Type

4.1Biological/Tissue Aortic
4.2Mechanical Aortic
Chapter 5

Aortic Valve Replacement Devices Market Size, Opportunities & Strategic Insights, by Surgical Approach

5.1Open-heart Surgery
5.2Minimally Invasive Surgery
Chapter 6

Aortic Valve Replacement Devices Market Size, Opportunities & Strategic Insights, by Patient Age Group

6.1Pediatric Patients
6.2Adult Patients
6.3Geriatric Patients
Chapter 7

Aortic Valve Replacement Devices Market Size, Opportunities & Strategic Insights, by Implantation Procedure

7.1Transfemoral approach
7.2Transapical approach
Chapter 8

Aortic Valve Replacement Devices Market, by Region

8.1North America Aortic Valve Replacement Devices Market Size, Opportunities, Key Trends & Strategic Insights
8.1.1U.S.
8.1.2Canada
8.2Europe Aortic Valve Replacement Devices Market Size, Opportunities, Key Trends & Strategic Insights
8.2.1Germany
8.2.2France
8.2.3UK
8.2.4Italy
8.2.5The Netherlands
8.2.6Rest of EU
8.3Asia Pacific Aortic Valve Replacement Devices Market Size, Opportunities, Key Trends & Strategic Insights
8.3.1China
8.3.2Japan
8.3.3South Korea
8.3.4India
8.3.5Australia
8.3.6Thailand
8.3.7Rest of APAC
8.4Middle East & Africa Aortic Valve Replacement Devices Market Size, Opportunities, Key Trends & Strategic Insights
8.4.1Saudi Arabia
8.4.2United Arab Emirates
8.4.3South Africa
8.4.4Rest of MEA
8.5Latin America Aortic Valve Replacement Devices Market Size, Opportunities, Key Trends & Strategic Insights
8.5.1Brazil
8.5.2Mexico
8.5.3Rest of LA
8.6CIS Aortic Valve Replacement Devices Market Size, Opportunities, Key Trends & Strategic Insights
8.6.1Russia
8.6.2Rest of CIS
Chapter 9

Competitive Landscape

9.1Competitive Dashboard & Market Share Analysis
9.2Company Profiles (Overview, Financials, Developments, SWOT)
9.2.1Edwards Lifesciences Corporation
9.2.2Medtronic Plc
9.2.3Boston Scientific Corporation
9.2.4Jude Medical Inc
9.2.5CryoLife Inc
9.2.6Symetis SA
9.2.7Direct Flow medical Inc
9.2.8Jenavalve Technology Inc
9.2.9LivaNova Plc
9.2.10TTK HealthCare
9.2.11Colibri Heart Valve LLC
9.2.12Braile Biomdica